Discover 1,169 paid clinical trials in Montreal, Quebec. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,169
Sotevtamab (AB-16B5) Combined With FOLFOX as Neoadjuvant Treatment Prior to Resection of Colorectal Cancer Liver Metastasis
for
Metastatic Colorectal Cancer
Location: Montreal
Sponsor: Alethia Biotherapeutics
Sex: All
Age: 18+
Code: NCT06225843
Phase 2, Recruiting
Glycemic Control and Osteohealth in Adults Living With Type 1 Diabetes
for
Type 1 Diabetes
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Sex: All
Age: 18 - 70+
Code: NCT06158503
Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
for
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8,
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
for
Parkinsons Disease (PD)
Location: Montreal, Burlington VT, Boston MA, Providence RI,
Sponsor: BlueRock Therapeutics
Sex: All
Age: 45 - 70+
Code: NCT06944522
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
for
Solid Tumors, Hematologic Malignancies
Location: Montreal, Greenfield Park, Laval, Trois-Rivieres,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT03486873
Phase 3, Recruiting
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
for
Cervical Cancer
Location: Montreal, Scarborough ME, Manchester CT, Hartford CT,
Sponsor: GOG Foundation
Sex: Female
Age: 18+
Code: NCT04831580
Recruiting
Sustainable Implementation of the EXCEL Exercise Oncology Program Across Canada
for
Cancer, Prostate Cancers, Breast Cancers, Colon Cancer,
Location: Montreal, Toronto, Halifax, Calgary, Vancouver
Sponsor: University of Calgary
Sex: All
Age: 18+
Code: NCT06960291
Recruiting
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
for
Brain Metastases
Location: Montreal, Quebec, Syracuse NY, Boston MA, Toronto,
Sponsor: Canadian Cancer Trials Group
Sex: All
Age: 18+
Code: NCT03550391
Phase 3, Recruiting
A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor.
for
Metastatic Tumor
Location: Montreal, London, Vancouver
Sponsor: David Palma
Sex: All
Age: 18+
Code: NCT05717166
Phase 3, Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
for
Metastatic Castration-resistant Prostate Cancer (mCRPC),
Location: Montreal, Ottawa, Quebec, Syracuse NY, New Haven CT,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06136650
Phase 3, Recruiting
Comprehensive Analysis Platform To Understand, Remedy and Eliminate ALS
A Study to Assess the Safety, Tolerability, and Pharmacology of Darifenacin in Patients With ALS
for
Amyotrophic Lateral Sclerosis
Location: Montreal, Ottawa
Sponsor: Oliver Blanchard
Sex: All
Age: 18 - 70+
Code: NCT06249867
Phase 2, Recruiting
Development of Eye-movement Based Biomarkers in Alzheimer's Disease
for
Alzheimer's Disease, Healthy Controls
Location: Ville-Marie, Montreal
Sponsor: McGill University
Sex: All
Age: 18+
Code: NCT05176704
Recruiting
Implementation of a Novel Functional Eye-Tracking Biomarker for Multiple Sclerosis
for
Clinically Isolated Syndrome,
Location: Montreal
Sponsor: McGill University
Sex: All
Age: 18 - 65
Code: NCT05277740
Recruiting
First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS)
for
Amyotrophic Lateral Sclerosis (ALS),
Location: Montreal, Toronto, London, Edmonton
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06351592
Phase 1, Phase 2, Recruiting
First-in-Human Study of ALN-SNCA in Adult Participants With Early Parkinson's Disease (PD)
for
Parkinsons Disease
Location: Montreal, Ottawa
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 50 - 70+
Code: NCT07216066
Phase 1, Recruiting
A First in Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of EDK060 in Adults With CMT1A.
for
Charcot-Marie-Tooth Disease, Type 1A
Location: Montreal, Sherbrooke, Ottawa
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 60
Code: NCT07140614
Phase 1, Recruiting
A Study to Investigate the Safety, Tolerability, and Efficacy of SAR446268, an Adeno-associated Viral Vector-mediated Gene Therapy in Participants Aged 10 to 55 Years of Age With Non-congenital Myotonic Dystrophy Type 1
for
Myotonic Dystrophy
Location: Montreal, New York NY, Philadelphia PA, Richmond VA,
Sponsor: Sanofi
Sex: All
Age: 10 - 55
Code: NCT06844214
Phase 1, Phase 2, Recruiting
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity